Torrid Stock Discussion

4/1/2024 🦍’s Watchlist 🚨⚡️🚨⚡️🚨⚡️🚨
$Yield10 Bioscience(YTEN.US)$ $Lytus Technologies Holdings(LYT.US)$ $Avalo Therapeutics(AVTX.US)$ $Gamida Cell(GMDA.US)$ $Torrid(CURV.US)$ $Qilian International(QLI.US)$
📊⚡️📊

$Torrid(CURV.US)$
📊⚡️📊

$Torrid(CURV.US)$ rose more than 25% after hours Thursday after the plus-sized clothing maker beat analyst estimates for Q4 revenues and overall results.
CURV soared 26% to trade at $6.15 shortly before 4:45 p.m. ET after the company reported a $0.04 loss per share – narrower than the $0.07 analysts had reportedly expected.
The company also recorded $293.5 million of quarterly revenues vs. the $276....

MBIA ( $MBIA(MBI.US)$ ) stock is rocketing more than 58% after declaring a special cash dividend.
Exicure ( $Exicure(XCUR.US)$ ) shares are soaring over 55% alongside heavy pre-market trading.
FLJ ( $FLJ Group(FLJ.US)$ ) stock is surging close to 45% with strong early morning trading.
Torrid ( $Torrid(CURV.US)$ ) shares are gaining more than 16% after releasing its Q3 earnings report.
Meta Materials ( $Meta Materials(MMAT.US)$ ) stock is increasing ...

The increasing demand for GLP-1 weight-loss medications indicates that in the next ten years, a significant number of Americans may lose hundreds of millions of pounds collectively. This shift in weight could cause a redistribution of trillions of dollars.
Last week, $Novo-Nordisk A/S(NVO.US)$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...